126
Wang C, et al. Sci China Chem January (2012) Vol.55 No.1
3,5-dichloro BODIPY caused the products to have quite
different absorption and emission spectra [32, 40].
(trifluoromethyl)benzene (9 mg, 0.05 mmol) were suspend-
ed in a 7:3 mixture (V/V) of ethanol and water (8 mL).
Copper sulfate (3 mg, 0.015 mmol), sodium ascorbate (6 mg,
0.03 mmol) and tris[(N-benzyltriazolyl)-methyl]amine lig-
and (8 mg, 0.015 mmol) were added. The mixture was then
stirred at room temperature for 12–16 h, and monitored by
TLC. EtOAc (20 mL 2) were added to extract the product.
The combined organic layers were washed with brine and
dried over anhydrous Na2SO4. The solvent was removed
under vacuum and the resulting residue was purified with
flash chromatography on silica gel to get the triazole com-
pound as a yellow solid (22 mg, 89%).
Based on our previous study, we postulated that when an
azido group is introduced to the 3-position of the BODIPY
core, the electron donating effect of the -nitrogen of the
azido group will quench the fluorescence via an ICT pro-
cess. Upon CuAAC reaction with a terminal alkyne, the
formation of triazole ring will lower the electron donating
ability of this nitrogen, release the fluorescence quenching,
and lead to a fluorogenic phenomenon [3].
1
2 Experimental
6: H NMR (300 MHz, CDCl3): δ (ppm) 9.12 (s, 1 H),
7.94 (s, 1 H), 7.73–7.69 (m, 2 H), 7.57 (d, J = 8.1 Hz, 2 H),
7.45–7.39 (m, 2 H), 7.15 (s, 1 H), 7.17–7.01 (m, 4 H), 6.62
(s, 1 H), 3.92 (s, 3 H); 13C NMR (100 MHz, CDCl3): δ (ppm)
146.1, 135.4, 130.5, 130.2, 129.6, 128.7, 127.8, 126.6,
125.9, 125.6, 125.5, 125.1, 124.4, 120.9, 55.5, 45.9. HRMS
calculated for C24H17BF3N5O (M+): m/z 459.1593, found
m/z 459.1587.
2.1 General experimental section
Chemical reagents and solvents were purchased from VWR
Scientific, and were used without further purification. H
1
NMR spectra were recorded on Varian 300 NMR spectrom-
eter and the chemical shifts were reported relative to TMS.
13C NMR spectra were recorded either on Varian 300 NMR
or Varian 400 NMR spectrometer. Analytical thin-layer
chromatography (TLC) was performed on silica 60F-254
plates. Flash column chromatography was carried out on
silica gel. The UV-vis absorption spectra were measured on
Agilent 8453 spectrometer. Emission spectra were meas-
ured on Varian Cary Eclipse fluorescence spectrophotome-
ter. Fluorescent microcopy was performed on Olympus IX
86. RPMI 1640 without folic acid and Dulbecco’s Modified
Eagle’s Medium (DMEM) were purchased from Invitrogen
(Carlsbad, CA). KB cells and Human Mesenchymal Stem
Cell (HMSCs) were purchased from ATCC.
1
7: H NMR (300 MHz, CDCl3): δ (ppm) 9.08 (s, 1 H),
7.91 (s, 1 H), 7.87 (d, J = 8.1 Hz, 2 H), 7.55 (d, J = 8.1 Hz,
2 H), 7.28 (d, J = 8.1 Hz, 2 H), 7.18 (d, J = 4.2 Hz, 1 H),
7.09–7.06 (m, 3 H), 6.99 (d, J = 2.1 Hz, 1 H), 6.63 (s, 1 H),
3.92 (s, 3 H), 2.65 (t, J = 7.2 Hz, 2 H), 1.67–1.63 (m, 2 H),
1.37–1.34 (m, 4 H), 0.92–0.82 (m, 3 H); 13C NMR (75 MHz,
CDCl3): δ (ppm) 162.3, 148.4, 147.1, 143.6, 143.3, 139.3,
134.3, 133.4, 132.5, 132.4, 131.1, 128.9, 127.2, 126.1,
125.8, 120.3, 120.2, 120.1, 119.0, 114.1, 113.0, 55.6, 35.8,
33.2, 31.9, 22.6, 14.0. HRMS calculated for C29H28BF2N5O
(M+): m/z 511.2469, found m/z 511.2483.
8: 1H NMR (300 MHz, CDCl3): δ (ppm) 9.11 (s, 1 H),
7.64 (s, 1 H),7.51–7.46 (m, 2H), 7.22 (d, J = 3.6 Hz, 1 H),
7.03–7.00 (m, 3 H), 6.76–6.75 (m, 1 H), 6.45–6.43 (m, 1 H),
5.23 (s, 1 H), 5.13 (s, 1 H), 3.89 (s, 3 H), 3.26 (s, 3 H); 13C
NMR (75 MHz, CDCl3): δ (ppm) 167.2, 160.5, 151.0, 141.5,
137.4, 136.4, 133.8, 132.5, 131.0, 130.0, 125.8, 125.2,
116.9, 115.0, 113.0, 112.0, 54.5, 21.3.
2.2 Synthesis of azido BODIPY 5 and sequential Cu-
AAC reaction
2.2.1 Synthesis of azido BODIPY 5
To 30 mL acetonitrile solution of monochloride BODIPY 4
[41–43] (240 mg, 0.69 mmol), 3 equivalents of sodium
azide (134 mg, 2.07 mmol) were added. The mixture was
stirred in dark at room temperature for 3 h, monitored with
TLC. The reaction was concentrated under vacuum and the
resulting residue was purified by chromatography to get
1
9: H NMR (400 MHz, CDCl3): δ (ppm) 8.63 (s, 1 H),
7.88 (s, 1 H), 7.54 (d, J = 9.0 Hz, 2 H), 7.17–7.05 (m, 3 H),
6.98–6.97 (m, 1 H), 6.60–6.59 (m, 1 H), 3.91 (s, 3 H), 3.71
(t, J = 4.5 Hz, 2 H), 2.88 (t, J = 5.7 Hz, 2 H), 1.89–1.84 (m,
2 H), 1.75 - 1.67 (m, 2 H); 13C NMR (100 MHz, CDCl3): δ
(ppm) 162.2, 148.5, 147.3, 147.2, 143.2, 134.2, 133.3, 132.4,
131.1, 125.8, 122.3, 122.2, 122.1, 118.9, 114.2, 112.9, 62.6,
55.6, 32.2, 30.0, 25.3. HRMS calculated for C22H22BF2N5O2
(M+): m/z 437.1949, found m/z 437.1957.
1
BODIPY 5 as a red solid (210 mg, 86%). H NMR (400
MHz, CDCl3): δ (ppm) 7.79 (s, 1 H), 7.48 (d, J = 8.4 Hz, 2
H), 7.04 (d, J = 8.4 Hz, 2 H), 6.99 (d, J = 4.8 Hz, 1 H), 6.84
(d, J = 4.2 Hz, 1 H), 6.50 (m, 1 H), 6.35 (d, J = 4.2 Hz, 1 H),
3.91 (s, 3 H); 13C NMR (100 MHz, CDCl3): δ (ppm) 161.8,
152.4, 144.0, 140.8, 134.0, 133.3, 132.9, 132.2, 128.8,
125.9, 117.4, 114.1, 109.9, 55.5; HRMS calculated for
(C16H12BF2N5O + Na)+: m/z 345.1607, found m/z 345.1613.
1
10: H NMR (300 MHz, CDCl3): δ (ppm) 9.17 (s, 1 H),
8.07 (d, J = 6.6 Hz, 2 H), 7.94 (s, 1 H), 7.74–7.65 (m, 4 H),
7.58 (d, J = 6.6 Hz, 2 H), 7.50–7.45 (m, 2 H), 7.40–7.35 (m,
1 H), 7.21 (d, J = 4.5 Hz, 1 H), 7.11–7.07 (m, 3 H), 7.02 (s,
1 H), 6.64 (s, 1 H), 3.94 (s, 3 H); HRMS calculated for
C30H22BF2N5O (M+): m/z 517.2000, found m/z 517.2005.
11: 1H NMR (300 MHz, DMSO): δ (ppm) 8.98 (s, 1 H),
7.90 (s, 1 H), 7.81 (d, J = 8.7 Hz, 2 H), 7.56 (d, J = 8.4 Hz,
2.2.2 Typical experimental procedure for CuAAC reac-
tions
Azido BODIPY 5 (17 mg, 0.05 mmol), 1-ethynyl-3-